Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGNX Regenxbio Inc

已收盘 07-02 16:00:00 EDT

10.75

-0.32

-2.89%

盘后10.75

+0.000.00%

17:06 EDT

最高11.07	最低10.72	成交量50.79万
今开11.02	昨收11.07	日振幅3.16%
总市值5.30亿	流通市值4.37亿	总股本4,926万
成交额550.29万	换手率1.25%	流通股本4,068万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGNX","market":"US","secType":"STK","nameCN":"Regenxbio Inc","latestPrice":10.75,"timestamp":1719950400000,"preClose":11.07,"halted":0,"volume":507888,"hourTrading":{"tag":"盘后","latestPrice":10.75,"preClose":10.75,"latestTime":"17:06 EDT","volume":26396,"amount":283753.33,"timestamp":1719954383805},"delay":0,"floatShares":40682009,"shares":49255966,"eps":-5.871818,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.32,"latestTime":"07-02 16:00:00 EDT","open":11.02,"high":11.0699,"low":10.72,"amount":5502900.45456,"amplitude":0.031608,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.871818,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"listingDate":1442462400000,"adjPreClose":11.07,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":10.75,"preClose":10.75,"latestTime":"17:06 EDT","volume":26396,"amount":283753.33,"timestamp":1719954383805},"volumeRatio":0.702989,"impliedVol":0.7054,"impliedVolPercentile":0.3214},"requestUrl":"/m/hq/s/RGNX","defaultTab":"news","newsList":[{"id":"2448945549","title":"Regenxbio Inc.盘中异动 大幅跳水5.04%报11.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448945549","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448945549?lang=zh_cn&edition=full","pubTime":"2024-07-02 01:37","pubTimestamp":1719855450,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日01时37分，Regenxbio Inc.股票出现波动，股价大幅下跌5.04%。截至发稿，该股报11.11美元/股，成交量23.4425万股，换手率0.48%，振幅5.81%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Senti Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为737.55%、193.46%、119.65%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为101.49%、68.38%、56.57%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702013731af900b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702013731af900b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4505","BK4139","RGNX"],"gpt_icon":0},{"id":"2446922363","title":"Regenxbio Inc.盘中异动 大幅下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446922363","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446922363?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:31","pubTimestamp":1719412283,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时31分，Regenxbio Inc.股票出现波动，股价快速下挫5.11%。截至发稿，该股报11.69美元/股，成交量6.1812万股，换手率0.13%，振幅4.30%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223123af8f5994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223123af8f5994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4505","BK4139","BK4563"],"gpt_icon":0},{"id":"2446100734","title":"Regenxbio Inc.盘中异动 下午盘股价大涨5.07%报12.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446100734","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446100734?lang=zh_cn&edition=full","pubTime":"2024-06-25 01:30","pubTimestamp":1719250251,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日01时30分，Regenxbio Inc.股票出现波动，股价大幅拉升5.07%。截至发稿，该股报12.63美元/股，成交量31.1127万股，换手率0.63%，振幅5.41%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为1.91%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。该信息摘要如下：美银证券分析师Alec Stranahan维持$Regenxbio $买入评级，并将目标价从35美元下调至33美元。根据TipRanks数据显示，该分析师近一年总胜率为48.9%，总平均回报率为-2.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625013051af8ef0ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625013051af8ef0ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2445973062","title":"Sarepta 因投资者欢呼基因疗法应用范围扩大而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2445973062","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445973062?lang=zh_cn&edition=full","pubTime":"2024-06-21 18:46","pubTimestamp":1718966785,"startTime":"0","endTime":"0","summary":"    路透6月21日 - Sarepta Therapeutics   股价周五在盘前交易中大涨约36%，原因是该公司为杜氏肌营养不良症患者提供的基因疗法获得了扩大使用范围的批准，从而在美国打开了更大的市场。Biliouris 预计，Elevidys 将成为 DMD 基因疗法的 \"主导\"，在 2027 年之前不会出现短期竞争。同时，Sarepta 公司将于美国东部时间上午 08:30 与投资者举行电话会议，讨论扩大批准范围的事宜。周五，Sarepta 公司的市盈率为 12.52，而 RegenxBio 公司的市盈率为 1.49。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","SG9999013999.USD","IE00BLSP4452.SGD","SG9999001176.USD","SG9999011175.SGD","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","LU1023059063.AUD","SG9999003800.SGD","SRPT","BK4139","LU0170899867.USD","BK4588","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0234572021.USD","BK4550","IE00BBT3K403.USD","LU0058720904.USD","SGXZ57979304.SGD","IE00B2B36J28.USD","BK4534","LU1066051498.USD","LU1066053197.SGD","BK4581","BK4568","SG9999001176.SGD","PFE","LU0321505868.SGD","IE0002270589.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1057294990.SGD","BK4592","IE00BLSP4239.USD","LU0122379950.USD","BK4505","SG9999002224.SGD","BK4563","LU0321505439.SGD","RGNX","LU0456855351.SGD","BK4585","IE00B19Z3581.USD","BK4007","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2444125782","title":"Regenxbio Inc.盘中异动 早盘股价大跌5.49%报11.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444125782","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444125782?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:42","pubTimestamp":1718890944,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时42分，Regenxbio Inc.股票出现异动，股价急速下挫5.49%。截至发稿，该股报11.54美元/股，成交量2.9996万股，换手率0.06%，振幅4.73%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214224968157ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214224968157ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2444847113","title":"Regenxbio Inc.盘中异动 大幅下跌5.08%报11.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444847113","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444847113?lang=zh_cn&edition=full","pubTime":"2024-06-18 02:25","pubTimestamp":1718648720,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日02时25分，Regenxbio Inc.股票出现异动，股价急速下挫5.08%。截至发稿，该股报11.78美元/股，成交量31.1126万股，换手率0.63%，振幅3.79%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618022520941ef050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618022520941ef050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","BK4505","RGNX"],"gpt_icon":0},{"id":"2443607433","title":"Regenxbio Inc.盘中异动 临近收盘急速跳水5.01%报12.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443607433","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443607433?lang=zh_cn&edition=full","pubTime":"2024-06-15 03:56","pubTimestamp":1718395013,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日03时56分，Regenxbio Inc.股票出现异动，股价急速跳水5.01%。截至发稿，该股报12.43美元/股，成交量33.715万股，换手率0.68%，振幅3.98%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615035653941eeb9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615035653941eeb9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","RGNX","BK4139","BK4505"],"gpt_icon":0},{"id":"2442829792","title":"Regenxbio Inc.盘中异动 大幅下挫5.11%报13.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442829792","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442829792?lang=zh_cn&edition=full","pubTime":"2024-06-11 00:28","pubTimestamp":1718036904,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日00时28分，Regenxbio Inc.股票出现波动，股价快速跳水5.11%。截至发稿，该股报13.36美元/股，成交量23.2656万股，换手率0.47%，振幅3.84%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611002824941ed71b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611002824941ed71b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4563","RGNX"],"gpt_icon":0},{"id":"2439101503","title":"Regenxbio Inc.盘中异动 股价大跌5.05%报14.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439101503","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439101503?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:01","pubTimestamp":1717002109,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时01分，Regenxbio Inc.股票出现异动，股价急速跳水5.05%。截至发稿，该股报14.21美元/股，成交量12.8087万股，换手率0.26%，振幅3.94%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530010149aef25a22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530010149aef25a22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4505","BK4563"],"gpt_icon":0},{"id":"2435654085","title":"HC Wainwright & Co.：维持Regenxbio(RGNX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至38.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435654085","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435654085?lang=zh_cn&edition=full","pubTime":"2024-05-15 23:34","pubTimestamp":1715787292,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Regenxbio(RGNX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152334578b0bb26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152334578b0bb26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX"],"gpt_icon":0},{"id":"2434651013","title":"Regenxbio Inc.盘中异动 急速下跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434651013","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434651013?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:36","pubTimestamp":1715261799,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时36分，Regenxbio Inc.股票出现异动，股价大幅下跌5.55%。截至发稿，该股报15.75美元/股，成交量1.1166万股，换手率0.02%，振幅3.45%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092136407926c8a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092136407926c8a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2433950172","title":"Regenxbio Inc    预计每股亏损 1.26 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433950172","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433950172?lang=zh_cn&edition=full","pubTime":"2024-05-07 10:58","pubTimestamp":1715050702,"startTime":"0","endTime":"0","summary":"   * Regenxbio Inc    将于5月8日发布截至2024年3月31日的季度财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于马里兰州罗克维尔的公司的营收将从去年同期的1914万美元增长22.9%，达到2352.5万美元。* LSEG分析师对Regenxbio公司的平均预期是每股亏损1.26美元。* 华尔街对 Regenxbio Inc 的 12 个月目标价中位数为 39.50 美元，高于其最新收盘价 16.87 美元。5月7日 - 以前的季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNX"],"gpt_icon":0},{"id":"2432970612","title":"Regenxbio Inc.盘中异动 股价大涨5.23%报17.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432970612","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432970612?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:36","pubTimestamp":1714743382,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时36分，Regenxbio Inc.股票出现异动，股价急速上涨5.23%。截至发稿，该股报17.51美元/股，成交量8257股，换手率0.02%，振幅1.38%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Vaxxinity, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Ardelyx, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为77.35%、23.48%、12.57%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.，振幅分别为26.55%、15.86%、15.78%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032136237925c0e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032136237925c0e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4505","BK4563"],"gpt_icon":0},{"id":"2431446830","title":"Regenxbio Inc    预计每股亏损 1.26 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431446830","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431446830?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:31","pubTimestamp":1714390269,"startTime":"0","endTime":"0","summary":"   * Regenxbio Inc    预计将在5月1日公布截至2024年3月31日的季度业绩(预计)，季度收入将有所增长。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于马里兰州罗克维尔的公司的营收预计将从去年同期的1914万美元增长22.9%，达到2352.5万美元。* LSEG分析师对Regenxbio公司的平均预期是每股亏损1.26美元。* 华尔街对 Regenxbio Inc 的 12 个月目标价中位数为 39.50 美元，高于其最新收盘价 16.19 美元。4月29日 - 以前的季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNX"],"gpt_icon":0},{"id":"2428464445","title":"Regenxbio Inc.盘中异动 急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428464445","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428464445?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:57","pubTimestamp":1713466628,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时57分，Regenxbio Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报16.17美元/股，成交量23.6136万股，换手率0.48%，振幅3.64%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190257087a53d1c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190257087a53d1c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4505","BK4139","BK4563"],"gpt_icon":0},{"id":"2427751393","title":"Regenxbio Inc.盘中异动 快速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427751393","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427751393?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:41","pubTimestamp":1712947279,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时41分，Regenxbio Inc.股票出现异动，股价快速下挫5.10%。截至发稿，该股报18.05美元/股，成交量30.9268万股，换手率0.63%，振幅6.89%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为1.56%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130241197a527b8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130241197a527b8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","RGNX","BK4505"],"gpt_icon":0},{"id":"2425347254","title":"Regenxbio Inc.盘中异动 大幅下挫5.04%报19.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425347254","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425347254?lang=zh_cn&edition=full","pubTime":"2024-04-05 03:34","pubTimestamp":1712259275,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日03时34分，Regenxbio Inc.股票出现波动，股价快速下跌5.04%。截至发稿，该股报19.23美元/股，成交量28.6452万股，换手率0.58%，振幅7.49%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为1.39%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405033435791ecf97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405033435791ecf97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4563","BK4139","RGNX"],"gpt_icon":0},{"id":"2424704177","title":"Regenxbio Inc.盘中异动 早盘大幅下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424704177","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424704177?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:10","pubTimestamp":1712067037,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时10分，Regenxbio Inc.股票出现波动，股价急速下挫5.11%。截至发稿，该股报20.43美元/股，成交量6.0601万股，换手率0.12%，振幅3.30%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为1.84%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402221037861e3045&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402221037861e3045&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4505","BK4139","RGNX"],"gpt_icon":0},{"id":"2419641095","title":"Regenxbio Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419641095","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2419641095?lang=zh_cn&edition=full","pubTime":"2024-03-13 02:53","pubTimestamp":1710269626,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日02时53分，Regenxbio Inc.股票出现波动，股价急速下挫5.08%。截至发稿，该股报21.69美元/股，成交量39.3978万股，换手率0.80%，振幅7.07%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313025346861dd91e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313025346861dd91e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","RGNX","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regenxbio.com","stockEarnings":[{"period":"1week","weight":-0.1345},{"period":"1month","weight":-0.2286},{"period":"3month","weight":-0.4544},{"period":"6month","weight":-0.3601},{"period":"1year","weight":-0.4462},{"period":"ytd","weight":-0.3833}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regenxbio Inc.于2008年7月16日成立。该公司是一家领先的生物技术公司，专注于重组腺相关病毒（AAV）基因疗法的发展，商业化和许可。在AAV基因治疗，病毒基因从所述AAV，一个小的非致病性感冒病毒除去，产生所谓的载体的生物递送载体。治疗性基因的序列然后被插入，形成重组载体。该公司专有的AAV基因交付平台（资产净值技术平台）包括专有权超过100新型AAV载体，包括AAV7，AAV8，AAV9和AAVrh10（NAV向量）。公司的使命是将患者的生命从严重的疾病，患有显著未满足的医疗需求，通过开发和商业化直接给予体内基因治疗产品，或者体内，根据其资产净值技术平台上。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.091191},{"month":2,"riseRate":0.333333,"avgChangeRate":0.042372},{"month":3,"riseRate":0.555556,"avgChangeRate":0.007107},{"month":4,"riseRate":0.555556,"avgChangeRate":0.001544},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.016188},{"month":6,"riseRate":0.666667,"avgChangeRate":0.061006},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.036194},{"month":8,"riseRate":0.375,"avgChangeRate":0.033668},{"month":9,"riseRate":0.625,"avgChangeRate":0.096755},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.090038},{"month":11,"riseRate":0.666667,"avgChangeRate":0.17903},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.046575}],"exchange":"NASDAQ","name":"Regenxbio Inc","nameEN":"Regenxbio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regenxbio Inc,RGNX,Regenxbio Inc股票,Regenxbio Inc股票老虎,Regenxbio Inc股票老虎国际,Regenxbio Inc行情,Regenxbio Inc股票行情,Regenxbio Inc股价,Regenxbio Inc股市,Regenxbio Inc股票价格,Regenxbio Inc股票交易,Regenxbio Inc股票购买,Regenxbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}